Skip to content
MedsAcross

Medicine

Dimethyl 240 mg delayed-release capsule

Dimethyl · Oral
Available on requestPrescription onlyUS FDAGeneric name

Dimethyl 240 mg delayed-release capsule is a generic prescription medicine for oral use, made by 17 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20 • C to 25 • C (68 • F to 77 • F), excursions permitted between 15…

Key facts

Active ingredient (INN)
Dimethyl
Brand
Sold under the generic name
Strength
240 mg
Dosage form
Delayed-release capsule
Route
Oral
Packs
60 capsules, 180 capsules, 1000 capsules and 25 more
Manufacturers
Ascend LaboratoriesIndiaCamber PharmaceuticalsIndiaAccord HealthcareIndiaMacleods PharmaceuticalsIndiaMSN LaboratoriesIndiaAurobindo PharmaIndiaCiplaIndiaDr. Reddy's LaboratoriesIndiaGolden State Medical SupplySolco Healthcare17 labelers on the register
Origin register
US FDA, United States
Storage
Store at 20 • C to 25 • C (68 • F to 77 • F), excursions permitted between 15 • C and 30 • C (59 • F and 86 • F). Store in original container.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
L04AX07 Dimethyl
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
24 September 2020
Identifiers
RxCUI 1373483, 1373491, 1373497DailyMed set ID a3677dce-a44b-481f-8a76-9ff3a4d42105, 7203a262-de0f-42dd-b4fb-8856758b82e9, 5361d5c6-c3eb-88e6-e063-6294a90ac08c +15NDC 16729-417, 43547-025, 70771-1531 +16Application ANDA210499, ANDA210414, ANDA210538 +9

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
60 capsule, delayed release in 1 bottle16729-417-12Accord HealthcareIndia13 January 2021
180 capsule, delayed release in 1 bottle16729-417-59Accord HealthcareIndia20 January 2021
1000 capsule, delayed release in 1 bottle, plastic67877-556-10Ascend LaboratoriesIndia26 September 2020
10 capsule, delayed release in 1 blister pack67877-556-33Ascend LaboratoriesIndia26 September 2020
46 capsule, delayed release in 1 bottle, plastic67877-556-46Ascend LaboratoriesIndia26 September 2020
60 capsule, delayed release in 1 bottle, plastic67877-556-60Ascend LaboratoriesIndia26 September 2020
90 capsule, delayed release in 1 bottle, plastic67877-556-90Ascend LaboratoriesIndia26 September 2020
60 capsule, delayed release in 1 bottle59651-084-60Aurobindo PharmaIndia22 December 2022
1 bottle in 1 carton / 46 capsule, delayed release in 1 bottle31722-658-31Camber PharmaceuticalsIndia24 September 2020
1 bottle in 1 carton / 60 capsule, delayed release in 1 bottle31722-658-32Camber PharmaceuticalsIndia24 September 2020
10 blister pack in 1 carton / 10 capsule, delayed release in 1 blister pack31722-658-33Camber PharmaceuticalsIndia24 September 2020
1 bottle, plastic in 1 carton / 60 capsule, delayed release in 1 bottle, plastic69097-323-03CiplaIndia24 September 2020
1 bottle in 1 carton / 60 capsule, delayed release in 1 bottle43598-430-60Dr. Reddy's LaboratoriesIndia25 September 2020
60 capsule, delayed release in 1 bottle33342-350-09Macleods PharmaceuticalsIndia26 June 2024
46 capsule, delayed release in 1 bottle33342-350-95Macleods PharmaceuticalsIndia27 June 2025
1 bottle in 1 carton / 500 capsule, delayed release in 1 bottle69539-043-05MSN LaboratoriesIndia28 September 2020
1 bottle in 1 carton / 60 capsule, delayed release in 1 bottle69539-043-60MSN LaboratoriesIndia28 September 2020
1 bottle in 1 carton / 60 capsule, delayed release in 1 bottle69238-1319-6Amneal Pharmaceuticals NY28 September 2020
60 capsule, delayed release in 1 bottle, plastic82249-747-60CivicaScript11 June 2025
1 bottle in 1 carton / 60 capsule, delayed release in 1 bottle70512-853-60SOLA Pharmaceuticals12 March 2023
60 capsule, delayed release in 1 bottle, plastic43547-025-06Solco Healthcare18 October 2022
46 capsule, delayed release in 1 bottle, plastic43547-025-46Solco Healthcare18 October 2022
500 capsule, delayed release in 1 bottle, plastic24979-128-02Upsher-Smith Laboratories1 December 2020
60 capsule, delayed release in 1 bottle, plastic24979-128-04Upsher-Smith Laboratories1 December 2020
60 capsule, delayed release in 1 bottle, plastic51407-441-60Golden State Medical Supply5 January 2021
60 capsule, delayed release in 1 bottle84677-030-60Golden State Medical Supply12 May 2026
1 capsule, delayed release in 1 kit50090-5288-0A-S Medication Solutions23 October 2020
1 bottle in 1 carton / 60 capsule, delayed release in 1 bottle82009-138-60Quallent Pharmaceuticals Health15 June 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 27 March 2013Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Dimethyl

Clinical summary

Dimethyl is a prescription medicine indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. MedsAcross supplies Dimethyl for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Dimethyl

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Dimethyl 240 mg delayed-release capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.